Product Details:
Generic Name | CELLCEPT 250 MG |
Treatment | CANCER.KIDNEY |
Composition | MYCOPHENOLATE MOFETIL CAPSULES |
Usage/Application | Hospital |
Packaging Size | box packing |
Packaging Type | box |
Dose/Strength | 250 mg |
Country of Origin | Made in India |
CellCept is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. CellCept 250 mg is not a controlled substance under the Controlled Substances Act